Research
Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)
This pilot study focuses on assessing the suitability and potential effectiveness of ketamine, a glutamate modulator, as a rapid treatment option for obsessive-compulsive disorder (OCD) symptoms in adolescents and young adults. Targeting a specific group of 6 individuals aged 14 to 22 with clinically significant OCD, the study seeks participants who have not responded adequately to at least one Serotonin Reuptake Inhibitor (SRI) medication and a course of Cognitive-Behavioral Therapy (CBT), unless these treatments were inaccessible or intolerable. Each participant will undergo a single session of intravenous ketamine infusion, followed by regular assessments over a 14-day period to monitor the treatment's efficacy. After this initial treatment phase, all participants will be offered a three-month open treatment program for OCD, which may include medication, CBT, or a combination of both. This approach aims to explore ketamine's role as a fast-acting therapeutic alternative for young individuals grappling with OCD, especially those who have found limited relief from conventional treatments.
Studies & Research
Ketamine in Major Depressive and Bipolar Disorder: A Meta-Analysis Review
Ketamine's Immediate and Extended Impact on Suicidality: A Medical Inpatient Study
Ketamine's Role in Reducing Alcohol Consumption: Targeting Maladaptive Reward Memories
Exploring Ketamine's Impact on Anxious Depression: MRI Insights into Brain Activity and Antidepressant Effects
Ketamine as a Dual Treatment for Depression and Alcohol Dependence: A Groundbreaking Study
Ketamine's Potential in Rapidly Reducing Suicidal Ideation: A Comparative Study
Late-Life Depression: Determining Optimal Ketamine Doses
Disclaimers
Financing Disclaimer: We offer two financing options for the Uplift Momentum Protocol™ (medical procedure): $325/month for 12 months, with a total cost of $3,900, no down payment, 0% APR, or $1,000 down payment and $237/month for 12 months, with a total cost of $3,844, 0% APR. Approval for both plans is based on internal criteria, including bank account history and a soft credit pull. Payments may be auto-withdrawn monthly. Both plans are subject to a $25 late fee for missed payments and other terms. Cancellation within 3 days of agreement is allowed. Governed by California law and AAA arbitration rules
Individuals showcased on KetamineUplift.com are actors, the content is not reflective of their thoughts, views, or perspectives.
Questions?
(310) 280-4440
care@ketamineuplift.com
4640 Admiralty Way
Suite 718A
Marina del Rey, CA 90292
© 2024 Ketamine Uplift | Terms & Conditions | Privacy Policy
Research
Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)
This pilot study focuses on assessing the suitability and potential effectiveness of ketamine, a glutamate modulator, as a rapid treatment option for obsessive-compulsive disorder (OCD) symptoms in adolescents and young adults. Targeting a specific group of 6 individuals aged 14 to 22 with clinically significant OCD, the study seeks participants who have not responded adequately to at least one Serotonin Reuptake Inhibitor (SRI) medication and a course of Cognitive-Behavioral Therapy (CBT), unless these treatments were inaccessible or intolerable. Each participant will undergo a single session of intravenous ketamine infusion, followed by regular assessments over a 14-day period to monitor the treatment's efficacy. After this initial treatment phase, all participants will be offered a three-month open treatment program for OCD, which may include medication, CBT, or a combination of both. This approach aims to explore ketamine's role as a fast-acting therapeutic alternative for young individuals grappling with OCD, especially those who have found limited relief from conventional treatments.
Studies & Research
Ketamine in Major Depressive and Bipolar Disorder: A Meta-Analysis Review
Ketamine's Immediate and Extended Impact on Suicidality: A Medical Inpatient Study
Ketamine's Role in Reducing Alcohol Consumption: Targeting Maladaptive Reward Memories
Exploring Ketamine's Impact on Anxious Depression: MRI Insights into Brain Activity and Antidepressant Effects
Ketamine as a Dual Treatment for Depression and Alcohol Dependence: A Groundbreaking Study
Ketamine's Potential in Rapidly Reducing Suicidal Ideation: A Comparative Study
Late-Life Depression: Determining Optimal Ketamine Doses
Disclaimers
Financing Disclaimer: We offer two financing options for the Uplift Momentum Protocol™ (medical procedure): $325/month for 12 months, with a total cost of $3,900, no down payment, 0% APR, or $1,000 down payment and $237/month for 12 months, with a total cost of $3,844, 0% APR. Approval for both plans is based on internal criteria, including bank account history and a soft credit pull. Payments may be auto-withdrawn monthly. Both plans are subject to a $25 late fee for missed payments and other terms. Cancellation within 3 days of agreement is allowed. Governed by California law and AAA arbitration rules
Individuals showcased on KetamineUplift.com are actors, the content is not reflective of their thoughts, views, or perspectives.
Questions?
(310) 280-4440
care@ketamineuplift.com
4640 Admiralty Way
Suite 718A
Marina del Rey, CA 90292
© 2024 Ketamine Uplift | Terms & Conditions | Privacy Policy